{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:42Z","timestamp":1792069902952,"version":"4.4.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/53\/2020-NCD-III"],"award-info":[{"award-number":["5\/13\/53\/2020-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["JCB\/2019\/000008"],"award-info":[{"award-number":["JCB\/2019\/000008"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10555-025-10248-4","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:39:33Z","timestamp":1739457573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4627-1566","authenticated-orcid":false,"given":"Priya","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9582-1909","authenticated-orcid":false,"given":"Ankita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-8636","authenticated-orcid":false,"given":"Suvendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-3276","authenticated-orcid":false,"given":"Ranabir","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8628-5128","authenticated-orcid":false,"given":"Subhayan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-3323","authenticated-orcid":false,"given":"Mahitosh","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"10248_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M., Morgan, E., Rumgay, H., et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast, 66, 15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"The Breast"},{"key":"10248_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka, A., Khan, F., Verma, B., et al. (2023). Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Communications, 43, 525\u2013561. https:\/\/doi.org\/10.1002\/cac2.12416","journal-title":"Cancer Communications"},{"key":"10248_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"M-Z Jin","year":"2020","unstructured":"Jin, M.-Z., & Jin, W.-L. (2020). The updated landscape of tumor microenvironment and drug repurposing. Signal Transduction and Targeted Therapy, 5, 166. https:\/\/doi.org\/10.1038\/s41392-020-00280-x","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10248_CR4","doi-asserted-by":"publisher","unstructured":"Akinsipe, T., Mohamedelhassan, R., Akinpelu, A., et al. (2024). Cellular interactions in tumor microenvironment during breast cancer progression: New frontiers and implications for novel therapeutics. Frontiers in Immunology, 15,. https:\/\/doi.org\/10.3389\/fimmu.2024.1302587","DOI":"10.3389\/fimmu.2024.1302587"},{"key":"10248_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-021-01949-z","volume":"40","author":"X Yan","year":"2021","unstructured":"Yan, X., Xie, Y., Yang, F., et al. (2021). Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. Journal of Experimental & Clinical Cancer Research, 40, 142. https:\/\/doi.org\/10.1186\/s13046-021-01949-z","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10248_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00280-020-04222-w","volume":"87","author":"U Mehraj","year":"2021","unstructured":"Mehraj, U., Dar, A. H., Wani, N. A., & Mir, M. A. (2021). Tumor microenvironment promotes breast cancer chemoresistance. Cancer Chemotherapy and Pharmacology, 87, 147\u2013158. https:\/\/doi.org\/10.1007\/s00280-020-04222-w","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10248_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.biochi.2010.11.010","volume":"93","author":"L Kular","year":"2011","unstructured":"Kular, L., Pakradouni, J., Kitabgi, P., et al. (2011). The CCN family: A new class of inflammation modulators? Biochimie, 93, 377\u2013388. https:\/\/doi.org\/10.1016\/j.biochi.2010.11.010","journal-title":"Biochimie"},{"key":"10248_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1083\/jcb.114.6.1285","volume":"114","author":"DM Bradham","year":"1991","unstructured":"Bradham, D. M., Igarashi, A., Potter, R. L., & Grotendorst, G. R. (1991). Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. Journal of Cell Biology, 114, 1285\u20131294. https:\/\/doi.org\/10.1083\/jcb.114.6.1285","journal-title":"Journal of Cell Biology"},{"key":"10248_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ijc.28972","volume":"137","author":"JE Wells","year":"2015","unstructured":"Wells, J. E., Howlett, M., Cole, C. H., & Kees, U. R. (2015). Deregulated expression of connective tissue growth factor ( CTGF \/ CCN2) is linked to poor outcome in human cancer. International Journal of Cancer, 137, 504\u2013511. https:\/\/doi.org\/10.1002\/ijc.28972","journal-title":"International Journal of Cancer"},{"key":"10248_CR10","doi-asserted-by":"publisher","first-page":"e2885","DOI":"10.1038\/cddis.2017.248","volume":"8","author":"H Zeng","year":"2017","unstructured":"Zeng, H., Yang, Z., Xu, N., et al. (2017). Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-\u03b21-dependent activation of Smad\/ERK signaling. Cell Death & Disease, 8, e2885\u2013e2885. https:\/\/doi.org\/10.1038\/cddis.2017.248","journal-title":"Cell Death & Disease"},{"key":"10248_CR11","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/ijc.25257","volume":"127","author":"D Yin","year":"2010","unstructured":"Yin, D., Chen, W., O\u2019Kelly, J., et al. (2010). Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. International Journal of Cancer, 127, 2257\u20132267. https:\/\/doi.org\/10.1002\/ijc.25257","journal-title":"International Journal of Cancer"},{"key":"10248_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.gastro.2004.10.007","volume":"128","author":"B-R Lin","year":"2005","unstructured":"Lin, B.-R., Chang, C.-C., Che, T.-F., et al. (2005). Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology, 128, 9\u201323. https:\/\/doi.org\/10.1053\/j.gastro.2004.10.007","journal-title":"Gastroenterology"},{"key":"10248_CR13","doi-asserted-by":"publisher","first-page":"36571","DOI":"10.1074\/jbc.M704141200","volume":"282","author":"Y-Z Deng","year":"2007","unstructured":"Deng, Y.-Z., Chen, P.-P., Wang, Y., et al. (2007). Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through \u03b2-catenin-T-cell factor\/Lef signaling. Journal of Biological Chemistry, 282, 36571\u201336581. https:\/\/doi.org\/10.1074\/jbc.M704141200","journal-title":"Journal of Biological Chemistry"},{"key":"10248_CR14","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn, I., Kundra, R., Mastrogiacomo, B., et al. (2023). Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Research, 83, 3861\u20133867. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816","journal-title":"Cancer Research"},{"key":"10248_CR15","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., et al. (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47, W556\u2013W560. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Research"},{"key":"10248_CR16","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T., Fu, J., Zeng, Z., et al. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48, W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Research"},{"key":"10248_CR17","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1038\/s41388-021-01731-7","volume":"40","author":"H Kim","year":"2021","unstructured":"Kim, H., Son, S., Ko, Y., & Shin, I. (2021). CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer. Oncogene, 40, 2667\u20132681. https:\/\/doi.org\/10.1038\/s41388-021-01731-7","journal-title":"Oncogene"},{"key":"10248_CR18","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1242\/jcs.03460","volume":"120","author":"P-S Chen","year":"2007","unstructured":"Chen, P.-S., Wang, M.-Y., Wu, S.-N., et al. (2007). CTGF enhances the motility of breast cancer cells via an integrin-\u03b1v\u03b23\u2013ERK1\/2-dependent S100A4-upregulated pathway. Journal of Cell Science, 120, 2053\u20132065. https:\/\/doi.org\/10.1242\/jcs.03460","journal-title":"Journal of Cell Science"},{"key":"10248_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3892\/ijo.2011.985","volume":"38","author":"W Chien","year":"2011","unstructured":"Chien, W., O\u2019Kelly, J., Lu, D., et al. (2011). Expression of connective tissue growth factor (CTGF\/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. International Journal of Oncology, 38, 1741\u20131747. https:\/\/doi.org\/10.3892\/ijo.2011.985","journal-title":"International Journal of Oncology"},{"key":"10248_CR20","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-08-2524","volume":"69","author":"MY Wang","year":"2009","unstructured":"Wang, M. Y., Chen, P. S., Prakash, E., et al. (2009). Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and clap1. Cancer Research, 69, 3482\u20133491. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2524","journal-title":"Cancer Research"},{"key":"10248_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i1.40","volume":"21","author":"JA Arnott","year":"2011","unstructured":"Arnott, J. A., Lambi, A. G., Mundy, C., et al. (2011). The role of connective tissue growth factor (CTGF\/CCN2) in skeletogenesis. Critical Reviews in Eukaryotic Gene Expression, 21, 43\u201369. https:\/\/doi.org\/10.1615\/CritRevEukarGeneExpr.v21.i1.40","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"key":"10248_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3892\/ijmm.2015.2390","volume":"36","author":"J Li","year":"2015","unstructured":"Li, J., Ye, L., Owen, S., et al. (2015). Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). International Journal of Molecular Medicine, 36, 1451\u20131463. https:\/\/doi.org\/10.3892\/ijmm.2015.2390","journal-title":"International Journal of Molecular Medicine"},{"key":"10248_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/BJ20081991","volume":"420","author":"E Aoyama","year":"2009","unstructured":"Aoyama, E., Hattori, T., Hoshijima, M., et al. (2009). N-terminal domains of CCN family 2\/connective tissue growth factor bind to aggrecan. Biochemical Journal, 420, 413\u2013420. https:\/\/doi.org\/10.1042\/BJ20081991","journal-title":"Biochemical Journal"},{"key":"10248_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12896-023-00776-8","volume":"23","author":"Y Qin","year":"2023","unstructured":"Qin, Y., Wu, G., Jin, J., et al. (2023). A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis. BMC Biotechnology, 23, 6. https:\/\/doi.org\/10.1186\/s12896-023-00776-8","journal-title":"BMC Biotechnology"},{"key":"10248_CR25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12079-021-00650-2","volume":"15","author":"V Zaykov","year":"2021","unstructured":"Zaykov, V., & Chaqour, B. (2021). The CCN2\/CTGF interactome: An approach to understanding the versatility of CCN2\/CTGF molecular activities. J Cell Commun Signal, 15, 567\u2013580. https:\/\/doi.org\/10.1007\/s12079-021-00650-2","journal-title":"J Cell Commun Signal"},{"key":"10248_CR26","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1242\/jcs.03270","volume":"119","author":"A Leask","year":"2006","unstructured":"Leask, A., & Abraham, D. J. (2006). All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. Journal of Cell Science, 119, 4803\u20134810. https:\/\/doi.org\/10.1242\/jcs.03270","journal-title":"Journal of Cell Science"},{"key":"10248_CR27","doi-asserted-by":"publisher","first-page":"37429","DOI":"10.1074\/jbc.M000976200","volume":"275","author":"A Hahn","year":"2000","unstructured":"Hahn, A., Heusinger-Ribeiro, J., Lanz, T., et al. (2000). Induction of connective tissue growth factor by activation of heptahelical receptors. Journal of Biological Chemistry, 275, 37429\u201337435. https:\/\/doi.org\/10.1074\/jbc.M000976200","journal-title":"Journal of Biological Chemistry"},{"key":"10248_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12079-007-0003-1","volume":"1","author":"B-L Huang","year":"2007","unstructured":"Huang, B.-L., Dornbach, L. M., & Lyons, K. M. (2007). The 5\u2032 untranslated regions (UTRs) of CCN1, CCN2, and CCN4 exhibit cryptic promoter activity. Journal of Cell Communication and Signaling, 1, 17\u201332. https:\/\/doi.org\/10.1007\/s12079-007-0003-1","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10248_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.onc.1209129","volume":"25","author":"S Kondo","year":"2006","unstructured":"Kondo, S., Kubota, S., Mukudai, Y., et al. (2006). Hypoxic regulation of stability of connective tissue growth factor\/CCN2 mRNA by 3\u2032-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene, 25, 1099\u20131110. https:\/\/doi.org\/10.1038\/sj.onc.1209129","journal-title":"Oncogene"},{"key":"10248_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbrc.2011.01.034","volume":"405","author":"S Kondo","year":"2011","unstructured":"Kondo, S., Kubota, S., Mukudai, Y., et al. (2011). Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA. Biochemical and Biophysical Research Communications, 405, 382\u2013387. https:\/\/doi.org\/10.1016\/j.bbrc.2011.01.034","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10248_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.bbrc.2004.04.108","volume":"318","author":"K-H Kim","year":"2004","unstructured":"Kim, K.-H., Park, G.-T., Lim, Y.-B., et al. (2004). Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-\u03b2-mediated signaling pathway. Biochemical and Biophysical Research Communications, 318, 819\u2013825. https:\/\/doi.org\/10.1016\/j.bbrc.2004.04.108","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10248_CR32","doi-asserted-by":"publisher","unstructured":"Lv, L., Liu, F.-R., Na, D., et al. (2020). Transforming growth factor-\u03b21 induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer. Bioscience Reports, 40,. https:\/\/doi.org\/10.1042\/BSR20201501","DOI":"10.1042\/BSR20201501"},{"key":"10248_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","volume":"3","author":"S Colak","year":"2017","unstructured":"Colak, S., & ten Dijke, P. (2017). Targeting TGF-\u03b2 signaling in cancer. Trends Cancer, 3, 56\u201371. https:\/\/doi.org\/10.1016\/j.trecan.2016.11.008","journal-title":"Trends Cancer"},{"key":"10248_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","volume":"209","author":"M Fujii","year":"2012","unstructured":"Fujii, M., Toyoda, T., Nakanishi, H., et al. (2012). TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. Journal of Experimental Medicine, 209, 479\u2013494. https:\/\/doi.org\/10.1084\/jem.20111653","journal-title":"Journal of Experimental Medicine"},{"key":"10248_CR35","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1159\/000085445","volume":"100","author":"MK Phanish","year":"2005","unstructured":"Phanish, M. K., Wahab, N. A., Hendry, B. M., & Dockrell, M. E. C. (2005). TGF-\u03b21-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras\/MEK\/ERK and Smad signalling. Nephron Experimental Nephrology, 100, e156\u2013e165. https:\/\/doi.org\/10.1159\/000085445","journal-title":"Nephron Experimental Nephrology"},{"key":"10248_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1165\/rcmb.4892","volume":"28","author":"M Utsugi","year":"2003","unstructured":"Utsugi, M., Dobashi, K., Ishizuka, T., et al. (2003). C-Jun-NH 2 -terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-\u03b21 in human lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 28, 754\u2013761. https:\/\/doi.org\/10.1165\/rcmb.4892","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10248_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-5926-6-5","volume":"6","author":"L Wickert","year":"2007","unstructured":"Wickert, L., Chatain, N., Kruschinsky, K., & Gressner, A. M. (2007). Glucocorticoids activate TGF-\u03b2 induced PAI-1 and CTGF expression in rat hepatocytes. Comparative Hepatology, 6, 5. https:\/\/doi.org\/10.1186\/1476-5926-6-5","journal-title":"Comparative Hepatology"},{"key":"10248_CR38","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/ijms21239084","volume":"21","author":"S-C Ou","year":"2020","unstructured":"Ou, S.-C., Bai, K.-J., Cheng, W.-H., et al. (2020). TGF-\u03b2 induced CTGF expression in human lung epithelial cells through ERK, ADAM17, RSK1, and C\/EBP\u03b2 pathways. International Journal of Molecular Sciences, 21, 9084. https:\/\/doi.org\/10.3390\/ijms21239084","journal-title":"International Journal of Molecular Sciences"},{"key":"10248_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0304-3835(01)00683-8","volume":"174","author":"T Shimo","year":"2001","unstructured":"Shimo, T., Kubota, S., Kondo, S., et al. (2001). Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Letters, 174, 57\u201364. https:\/\/doi.org\/10.1016\/S0304-3835(01)00683-8","journal-title":"Cancer Letters"},{"key":"10248_CR40","doi-asserted-by":"publisher","first-page":"F1223","DOI":"10.1152\/ajprenal.00245.2004","volume":"287","author":"DF Higgins","year":"2004","unstructured":"Higgins, D. F., Biju, M. P., Akai, Y., et al. (2004). Hypoxic induction of Ctgf is directly mediated by Hif-1. American Journal of Physiology-Renal Physiology, 287, F1223\u2013F1232. https:\/\/doi.org\/10.1152\/ajprenal.00245.2004","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"10248_CR41","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1093\/ndt\/gfp305","volume":"24","author":"S Kroening","year":"2009","unstructured":"Kroening, S., Neubauer, E., Wessel, J., et al. (2009). Hypoxia interferes with connective tissue growth factor (CTGF) gene expression in human proximal tubular cell lines. Nephrology Dialysis Transplantation, 24, 3319\u20133325. https:\/\/doi.org\/10.1093\/ndt\/gfp305","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10248_CR42","doi-asserted-by":"publisher","first-page":"e0188608","DOI":"10.1371\/journal.pone.0188608","volume":"12","author":"Y Cheng","year":"2017","unstructured":"Cheng, Y., Lin, C., Chen, J.-Y., et al. (2017). Correction: Induction of connective tissue growth factor expression by hypoxia in human lung fibroblasts via the MEKK1\/MEK1\/ERK1\/GLI-1\/GLI-2 and AP-1 pathways. PLoS ONE, 12, e0188608. https:\/\/doi.org\/10.1371\/journal.pone.0188608","journal-title":"PLoS ONE"},{"key":"10248_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.matbio.2019.09.003","volume":"87","author":"R Valle-Tenney","year":"2020","unstructured":"Valle-Tenney, R., Rebolledo, D. L., Lipson, K. E., & Brandan, E. (2020). Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-\u03b2 signaling upregulates CCN2\/CTGF expression specifically in muscle fibers. Matrix Biology, 87, 48\u201365. https:\/\/doi.org\/10.1016\/j.matbio.2019.09.003","journal-title":"Matrix Biology"},{"key":"10248_CR44","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s11095-008-9636-x","volume":"25","author":"R Rodrigues-D\u00edez","year":"2008","unstructured":"Rodrigues-D\u00edez, R., Carvajal-Gonz\u00e1lez, G., S\u00e1nchez-L\u00f3pez, E., et al. (2008). Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. Pharmaceutical Research, 25, 2447\u20132461. https:\/\/doi.org\/10.1007\/s11095-008-9636-x","journal-title":"Pharmaceutical Research"},{"key":"10248_CR45","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/01.CIR.0000165133.84978.E2","volume":"111","author":"J Rodr\u00edguez-Vita","year":"2005","unstructured":"Rodr\u00edguez-Vita, J., S\u00e1nchez-L\u00f3pez, E., Esteban, V., et al. (2005). Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-\u03b2\u2013independent mechanism. Circulation, 111, 2509\u20132517. https:\/\/doi.org\/10.1161\/01.CIR.0000165133.84978.E2","journal-title":"Circulation"},{"key":"10248_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/HYPERTENSIONAHA.107.091264","volume":"50","author":"M Rup\u00e9rez","year":"2007","unstructured":"Rup\u00e9rez, M., Rodrigues-D\u00edez, R., Blanco-Colio, L. M., et al. (2007). HMG-CoA reductase inhibitors decrease angiotensin II\u2013induced vascular fibrosis. Hypertension, 50, 377\u2013383. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.091264","journal-title":"Hypertension"},{"key":"10248_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cca.2006.05.029","volume":"373","author":"B-C Liu","year":"2006","unstructured":"Liu, B.-C., Zhang, J.-D., Zhang, X.-L., et al. (2006). Role of connective tissue growth factor (CTGF) module 4 in regulating epithelial mesenchymal transition (EMT) in HK-2 cells. Clinica Chimica Acta, 373, 144\u2013150. https:\/\/doi.org\/10.1016\/j.cca.2006.05.029","journal-title":"Clinica Chimica Acta"},{"key":"10248_CR48","doi-asserted-by":"publisher","first-page":"F149","DOI":"10.1152\/ajprenal.00129.2007","volume":"294","author":"E S\u00e1nchez-L\u00f3pez","year":"2008","unstructured":"S\u00e1nchez-L\u00f3pez, E., Rodriguez-Vita, J., Cartier, C., et al. (2008). Inhibitory effect of interleukin-1\u03b2 on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. American Journal of Physiology-Renal Physiology, 294, F149\u2013F160. https:\/\/doi.org\/10.1152\/ajprenal.00129.2007","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"10248_CR49","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"FH Epstein","year":"1994","unstructured":"Epstein, F. H., Border, W. A., & Noble, N. A. (1994). Transforming growth factor \u03b2 in tissue fibrosis. New England Journal of Medicine, 331, 1286\u20131292. https:\/\/doi.org\/10.1056\/NEJM199411103311907","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10248_CR50","first-page":"382","volume":"29","author":"M Ruiz-Ortega","year":"2009","unstructured":"Ruiz-Ortega, M., Jim\u00e9nez, F., Madrid, D., et al. (2009). Connective tissue growth factor (CTGF): A key factor in the onset and progression of kidney damage. Nefrolog\u00eda (English Edition), 29(5), 382\u2013391.","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"10248_CR51","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/jcb.22637","volume":"110","author":"D Nowinski","year":"2010","unstructured":"Nowinski, D., Koskela, A., Kiwanuka, E., et al. (2010). Inhibition of connective tissue growth factor\/CCN2 expression in human dermal fibroblasts by interleukin-1\u03b1 and \u03b2. Journal of Cellular Biochemistry, 110, 1226\u20131233. https:\/\/doi.org\/10.1002\/jcb.22637","journal-title":"Journal of Cellular Biochemistry"},{"key":"10248_CR52","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/hep.24587","volume":"54","author":"R Urtasun","year":"2011","unstructured":"Urtasun, R., Latasa, M. U., Demartis, M. I., et al. (2011). Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor\/yes-associated protein-mediated activation. Hepatology, 54, 2149\u20132158. https:\/\/doi.org\/10.1002\/hep.24587","journal-title":"Hepatology"},{"key":"10248_CR53","doi-asserted-by":"publisher","first-page":"19740","DOI":"10.1038\/s41598-023-47138-0","volume":"13","author":"C Inoue","year":"2023","unstructured":"Inoue, C., Mukai, K., Matsudaira, T., et al. (2023). PPP1R12A is a recycling endosomal phosphatase that facilitates YAP activation. Science and Reports, 13, 19740. https:\/\/doi.org\/10.1038\/s41598-023-47138-0","journal-title":"Science and Reports"},{"key":"10248_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.yjmcc.2008.11.017","volume":"46","author":"AG Recchia","year":"2009","unstructured":"Recchia, A. G., Filice, E., Pellegrino, D., et al. (2009). Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes. Journal of Molecular and Cellular Cardiology, 46, 352\u2013359. https:\/\/doi.org\/10.1016\/j.yjmcc.2008.11.017","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10248_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bcp.2014.01.030","volume":"88","author":"C-M Weng","year":"2014","unstructured":"Weng, C.-M., Yu, C.-C., Kuo, M.-L., et al. (2014). Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK\/AP-1 pathway. Biochemical Pharmacology, 88, 402\u2013411. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.030","journal-title":"Biochemical Pharmacology"},{"key":"10248_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-023-00931-5","volume":"30","author":"H-S Hua","year":"2023","unstructured":"Hua, H.-S., Wen, H.-C., Lee, H.-S., et al. (2023). Endothelin-1 induces connective tissue growth factor expression in human lung fibroblasts by disrupting HDAC2\/Sin3A\/MeCP2 corepressor complex. Journal of Biomedical Science, 30, 40. https:\/\/doi.org\/10.1186\/s12929-023-00931-5","journal-title":"Journal of Biomedical Science"},{"key":"10248_CR57","doi-asserted-by":"publisher","first-page":"40725","DOI":"10.1074\/jbc.M006509200","volume":"275","author":"K Suzuma","year":"2000","unstructured":"Suzuma, K., Naruse, K., Suzuma, I., et al. (2000). Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells. Journal of Biological Chemistry, 275, 40725\u201340731. https:\/\/doi.org\/10.1074\/jbc.M006509200","journal-title":"Journal of Biological Chemistry"},{"key":"10248_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/aps.2011.178","volume":"33","author":"W Ko","year":"2012","unstructured":"Ko, W., Chen, B., Hsu, M., et al. (2012). Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1\/JNK\/AP-1 pathway. Acta Pharmacologica Sinica, 33, 49\u201356. https:\/\/doi.org\/10.1038\/aps.2011.178","journal-title":"Acta Pharmacologica Sinica"},{"key":"10248_CR59","doi-asserted-by":"publisher","first-page":"e19756","DOI":"10.1371\/journal.pone.0019756","volume":"6","author":"F Guo","year":"2011","unstructured":"Guo, F., Carter, D. E., & Leask, A. (2011). Mechanical tension increases CCN2\/CTGF expression and proliferation in gingival fibroblasts via a TGF\u03b2-dependent mechanism. PLoS ONE, 6, e19756. https:\/\/doi.org\/10.1371\/journal.pone.0019756","journal-title":"PLoS ONE"},{"key":"10248_CR60","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/iub.2126","volume":"71","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Chen, F., Jia, Q., & Hu, D. (2019). Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK\/STAT signaling pathway. IUBMB Life, 71, 1857\u20131875. https:\/\/doi.org\/10.1002\/iub.2126","journal-title":"IUBMB Life"},{"key":"10248_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters, R. F., Tijsen, A. J., Schroen, B., et al. (2009). miR-133 and miR-30 regulate connective tissue growth factor. Circulation Research, 104, 170\u2013178. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.182535","journal-title":"Circulation Research"},{"key":"10248_CR62","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/0008-5472.CAN-08-0987","volume":"69","author":"KL Bennewith","year":"2009","unstructured":"Bennewith, K. L., Huang, X., Ham, C. M., et al. (2009). The role of tumor cell-derived connective tissue growth factor (CTGF\/CCN2) in pancreatic tumor growth. Cancer Research, 69, 775\u2013784. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0987","journal-title":"Cancer Research"},{"key":"10248_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz029.015","volume":"30","author":"H Kim","year":"2019","unstructured":"Kim, H., & Son, S. (2019). Therapeutic potential of connective tissue growth factor (CTGF) in triple-negative breast cancer. Annals of Oncology, 30, i8. https:\/\/doi.org\/10.1093\/annonc\/mdz029.015","journal-title":"Annals of Oncology"},{"key":"10248_CR64","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13277-011-0173-6","volume":"32","author":"L Cui","year":"2011","unstructured":"Cui, L., Zhang, Q., Mao, Z., et al. (2011). CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumor Biology, 32, 721\u2013728. https:\/\/doi.org\/10.1007\/s13277-011-0173-6","journal-title":"Tumor Biology"},{"key":"10248_CR65","first-page":"3794","volume":"124","author":"X-Q Jia","year":"2011","unstructured":"Jia, X.-Q., Cheng, H.-Q., Li, H., et al. (2011). Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chinese Medical Journal (Engl), 124, 3794\u20133799.","journal-title":"Chinese Medical Journal (Engl)"},{"key":"10248_CR66","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.4161\/cc.20717","volume":"11","author":"C Capparelli","year":"2012","unstructured":"Capparelli, C., Whitaker-Menezes, D., Guido, C., et al. (2012). CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle, 11, 2272\u20132284. https:\/\/doi.org\/10.4161\/cc.20717","journal-title":"Cell Cycle"},{"key":"10248_CR67","first-page":"4222","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang, S., Liu, K., Han, X., et al. (2023). ATXN3 deubiquitinates YAP1 to promote tumor growth. American Journal of Cancer Research, 13, 4222\u20134234.","journal-title":"American Journal of Cancer Research"},{"key":"10248_CR68","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/bs.acr.2016.07.005","volume":"132","author":"V Te Boekhorst","year":"2016","unstructured":"Te Boekhorst, V., & Friedl, P. (2016). Plasticity of cancer cell invasion\u2014mechanisms and implications for therapy. Advances in Cancer Research, 132, 209\u2013264.","journal-title":"Advances in Cancer Research"},{"key":"10248_CR69","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1078\/0171-9335-00421","volume":"83","author":"G Kirfel","year":"2004","unstructured":"Kirfel, G., Rigort, A., Borm, B., & Herzog, V. (2004). Cell migration: Mechanisms of rear detachment and the formation of migration tracks. European Journal of Cell Biology, 83, 717\u2013724. https:\/\/doi.org\/10.1078\/0171-9335-00421","journal-title":"European Journal of Cell Biology"},{"key":"10248_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2164-9-54","volume":"9","author":"T Demuth","year":"2008","unstructured":"Demuth, T., Rennert, J. L., Hoelzinger, D. B., et al. (2008). Glioma cells on the run \u2013 The migratory transcriptome of 10 human glioma cell lines. BMC Genomics, 9, 54. https:\/\/doi.org\/10.1186\/1471-2164-9-54","journal-title":"BMC Genomics"},{"key":"10248_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1349-7006.2010.01746.x","volume":"102","author":"Z Mao","year":"2011","unstructured":"Mao, Z., Ma, X., Rong, Y., et al. (2011). Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NF-\u03baB pathway. Cancer Science, 102, 104\u2013110. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01746.x","journal-title":"Cancer Science"},{"key":"10248_CR72","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.3748\/wjg.v18.i47.7070","volume":"18","author":"M Xiu","year":"2012","unstructured":"Xiu, M. (2012). Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth. World Journal of Gastroenterology, 18, 7070. https:\/\/doi.org\/10.3748\/wjg.v18.i47.7070","journal-title":"World Journal of Gastroenterology"},{"key":"10248_CR73","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/bjc.2011.226","volume":"105","author":"S Braig","year":"2011","unstructured":"Braig, S., Wallner, S., Junglas, B., et al. (2011). CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. British Journal of Cancer, 105, 231\u2013238. https:\/\/doi.org\/10.1038\/bjc.2011.226","journal-title":"British Journal of Cancer"},{"key":"10248_CR74","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1172\/JCI42754","volume":"121","author":"H Ijichi","year":"2011","unstructured":"Ijichi, H., Chytil, A., Gorska, A. E., et al. (2011). Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. Journal of Clinical Investigation, 121, 4106\u20134117. https:\/\/doi.org\/10.1172\/JCI42754","journal-title":"Journal of Clinical Investigation"},{"key":"10248_CR75","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acsmedchemlett.3c00386","volume":"14","author":"A Fnaiche","year":"2023","unstructured":"Fnaiche, A., Chan, H.-C., Paquin, A., et al. (2023). Development of HC-258, a covalent acrylamide TEAD inhibitor that reduces gene expression and cell migration. ACS Medicinal Chemistry Letters, 14, 1746\u20131753. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00386","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10248_CR76","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1146\/annurev.bi.55.070186.005133","volume":"55","author":"LA Liotta","year":"1986","unstructured":"Liotta, L. A., Nageswara Rao, C. N., & Wewer, U. M. (1986). Biochemical interactions of tumor cells with the basement membrane. Annual Review of Biochemistry, 55, 1037\u20131057. https:\/\/doi.org\/10.1146\/annurev.bi.55.070186.005133","journal-title":"Annual Review of Biochemistry"},{"key":"10248_CR77","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L","volume":"71","author":"S Aznavoorian","year":"1993","unstructured":"Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., & Liotta, L. A. (1993). Molecular aspects of tumor cell invasion and metastasis. Cancer, 71, 1368\u20131383. https:\/\/doi.org\/10.1002\/1097-0142(19930215)71:4%3c1368::AID-CNCR2820710432%3e3.0.CO;2-L","journal-title":"Cancer"},{"key":"10248_CR78","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse, R., & Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circulation Research, 92, 827\u2013839. https:\/\/doi.org\/10.1161\/01.RES.0000070112.80711.3D","journal-title":"Circulation Research"},{"key":"10248_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev-pathol-020117-044127","volume":"13","author":"N Riggi","year":"2018","unstructured":"Riggi, N., Aguet, M., & Stamenkovic, I. (2018). Cancer metastasis: A reappraisal of its underlying mechanisms and their relevance to treatment. Annual Review of Pathology: Mechanisms of Disease, 13, 117\u2013140. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-044127","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"key":"10248_CR80","first-page":"462","volume":"7","author":"MS Pepper","year":"2001","unstructured":"Pepper, M. S. (2001). Lymphangiogenesis and tumor metastasis: Myth or reality? Clinical Cancer Research, 7, 462\u2013468.","journal-title":"Clinical Cancer Research"},{"key":"10248_CR81","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/jnci\/djh078","volume":"96","author":"DJV Griend","year":"2004","unstructured":"Griend, D. J. V., Berger, J. C., & Rinker-Schaeffer, C. W. (2004). Suppression of metastasis\u2013A new function for known proteins. JNCI Journal of the National Cancer Institute, 96, 344\u2013345. https:\/\/doi.org\/10.1093\/jnci\/djh078","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"10248_CR82","doi-asserted-by":"publisher","unstructured":"Vander Griend, D. J., & Rinker-Schaeffer, C. W. (2004). A new look at an old problem: The survival and organ-specific growth of metastases. Science\u2019s STKE, 2004,. https:\/\/doi.org\/10.1126\/stke.2162004pe3","DOI":"10.1126\/stke.2162004pe3"},{"key":"10248_CR83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12943-019-1044-9","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Niu, H., Ma, J., et al. (2019). The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma. Molecular Cancer, 18, 120. https:\/\/doi.org\/10.1186\/s12943-019-1044-9","journal-title":"Molecular Cancer"},{"key":"10248_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/hep.23285","volume":"51","author":"A Mazzocca","year":"2010","unstructured":"Mazzocca, A., Fransvea, E., Dituri, F., et al. (2010). Down-regulation of connective tissue growth factor by inhibition of transforming growth factor \u03b2 blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology, 51, 523\u2013534. https:\/\/doi.org\/10.1002\/hep.23285","journal-title":"Hepatology"},{"key":"10248_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J., Kang, Y., Serganova, I., et al. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. Journal of Clinical Investigation, 115, 44\u201355. https:\/\/doi.org\/10.1172\/JCI22320","journal-title":"Journal of Clinical Investigation"},{"key":"10248_CR86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/1471-2407-10-599","volume":"10","author":"IP Gorlov","year":"2010","unstructured":"Gorlov, I. P., Sircar, K., Zhao, H., et al. (2010). Prioritizing genes associated with prostate cancer development. BMC Cancer, 10, 599. https:\/\/doi.org\/10.1186\/1471-2407-10-599","journal-title":"BMC Cancer"},{"key":"10248_CR87","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1158\/0008-5472.CAN-06-0081","volume":"66","author":"N Dornh\u00f6fer","year":"2006","unstructured":"Dornh\u00f6fer, N., Spong, S., Bennewith, K., et al. (2006). Connective tissue growth factor\u2013specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Research, 66, 5816\u20135827. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0081","journal-title":"Cancer Research"},{"key":"10248_CR88","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y., Siegel, P. M., Shu, W., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537\u2013549. https:\/\/doi.org\/10.1016\/S1535-6108(03)00132-6","journal-title":"Cancer Cell"},{"key":"10248_CR89","doi-asserted-by":"publisher","first-page":"486","DOI":"10.5483\/BMBRep.2018.51.10.192","volume":"51","author":"H Kim","year":"2018","unstructured":"Kim, H., Son, S., & Shin, I. (2018). Role of the CCN protein family in cancer. BMB Reports, 51, 486\u2013492. https:\/\/doi.org\/10.5483\/BMBRep.2018.51.10.192","journal-title":"BMB Reports"},{"key":"10248_CR90","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","volume":"29","author":"S Casimiro","year":"2012","unstructured":"Casimiro, S., Luis, I., Fernandes, A., et al. (2012). Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clinical & Experimental Metastasis, 29, 155\u2013164. https:\/\/doi.org\/10.1007\/s10585-011-9438-0","journal-title":"Clinical & Experimental Metastasis"},{"key":"10248_CR91","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-1119(01)00619-9","volume":"274","author":"A Astolfi","year":"2001","unstructured":"Astolfi, A., De Giovanni, C., Landuzzi, L., et al. (2001). Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene, 274, 139\u2013149. https:\/\/doi.org\/10.1016\/S0378-1119(01)00619-9","journal-title":"Gene"},{"key":"10248_CR92","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jbmr.3869","volume":"35","author":"B Kim","year":"2020","unstructured":"Kim, B., Kim, H., Jung, S., et al. (2020). A CTGF-RUNX2-RANKL axis in breast and prostate cancer cells promotes tumor progression in bone. Journal of Bone and Mineral Research, 35, 155\u2013166. https:\/\/doi.org\/10.1002\/jbmr.3869","journal-title":"Journal of Bone and Mineral Research"},{"key":"10248_CR93","unstructured":"Chawla P, Gau D, Chen F et al (2023) MRTF activity in breast cancer cells promotes osteoclastogenesis through a paracrine action of CTGF. Preprint retrieved from https:\/\/www.biorxiv.org\/content\/10.1101\/2023.12.06.570453v1"},{"key":"10248_CR94","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J., Gupta, G. P., Siegel, P. M., et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature, 436, 518\u2013524. https:\/\/doi.org\/10.1038\/nature03799","journal-title":"Nature"},{"key":"10248_CR95","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1007\/s12325-023-02588-w","volume":"40","author":"Y-L Sun","year":"2023","unstructured":"Sun, Y.-L., Zhao, Y.-X., Guan, Y.-N., et al. (2023). Study on the relationship between differentially expressed proteins in breast cancer and lymph node metastasis. Advances in Therapy, 40, 4004\u20134023. https:\/\/doi.org\/10.1007\/s12325-023-02588-w","journal-title":"Advances in Therapy"},{"key":"10248_CR96","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I., Brisebarre, A., Sifrim, A., et al. (2018). Identification of the tumour transition states occurring during EMT. Nature, 556, 463\u2013468. https:\/\/doi.org\/10.1038\/s41586-018-0040-3","journal-title":"Nature"},{"key":"10248_CR97","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ncb826","volume":"4","author":"JG Abreu","year":"2002","unstructured":"Abreu, J. G., Ketpura, N. I., Reversade, B., & De Robertis, E. M. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-\u03b2. Nature Cell Biology, 4, 599\u2013604. https:\/\/doi.org\/10.1038\/ncb826","journal-title":"Nature Cell Biology"},{"key":"10248_CR98","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11033-013-2982-8","volume":"41","author":"W Ren","year":"2014","unstructured":"Ren, W., Sun, X., Wang, K., et al. (2014). BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Molecular Biology Reports, 41, 1373\u20131383. https:\/\/doi.org\/10.1007\/s11033-013-2982-8","journal-title":"Molecular Biology Reports"},{"key":"10248_CR99","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.yexcr.2005.03.022","volume":"307","author":"N Abdel Wahab","year":"2005","unstructured":"Abdel Wahab, N., Weston, B. S., & Mason, R. M. (2005). Modulation of the TGF\u03b2\/Smad signaling pathway in mesangial cells by CTGF\/CCN2. Experimental Cell Research, 307, 305\u2013314. https:\/\/doi.org\/10.1016\/j.yexcr.2005.03.022","journal-title":"Experimental Cell Research"},{"key":"10248_CR100","doi-asserted-by":"publisher","first-page":"25320","DOI":"10.18632\/oncotarget.4659","volume":"6","author":"X Zhu","year":"2015","unstructured":"Zhu, X., Zhong, J., Zhao, Z., et al. (2015). Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition. Oncotarget, 6, 25320\u201325338. https:\/\/doi.org\/10.18632\/oncotarget.4659","journal-title":"Oncotarget"},{"key":"10248_CR101","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/01.CIR.100.20.2108","volume":"100","author":"K Hishikawa","year":"1999","unstructured":"Hishikawa, K., Oemar, B. S., Tanner, F. C., et al. (1999). Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation, 100, 2108\u20132112. https:\/\/doi.org\/10.1161\/01.CIR.100.20.2108","journal-title":"Circulation"},{"key":"10248_CR102","doi-asserted-by":"publisher","first-page":"37461","DOI":"10.1074\/jbc.274.52.37461","volume":"274","author":"K Hishikawa","year":"1999","unstructured":"Hishikawa, K., Oemar, B. S., Tanner, F. C., et al. (1999). Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. Journal of Biological Chemistry, 274, 37461\u201337466. https:\/\/doi.org\/10.1074\/jbc.274.52.37461","journal-title":"Journal of Biological Chemistry"},{"key":"10248_CR103","doi-asserted-by":"publisher","unstructured":"Ren, Y., Du, C., Yan, L., et al. (2015). CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner. Drug Design, Development and Therapy, 4155,. https:\/\/doi.org\/10.2147\/DDDT.S86748","DOI":"10.2147\/DDDT.S86748"},{"key":"10248_CR104","doi-asserted-by":"publisher","unstructured":"Hamada, S., Masamune, A., & Shimosegawa, T. (2013). Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Frontiers in Physiology, 4,. https:\/\/doi.org\/10.3389\/fphys.2013.00331","DOI":"10.3389\/fphys.2013.00331"},{"key":"10248_CR105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.trecan.2016.04.005","volume":"2","author":"J Prakash","year":"2016","unstructured":"Prakash, J. (2016). Cancer-associated fibroblasts: Perspectives in cancer therapy. Trends Cancer, 2, 277\u2013279. https:\/\/doi.org\/10.1016\/j.trecan.2016.04.005","journal-title":"Trends Cancer"},{"key":"10248_CR106","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori, M. E., Di Franco, S., Villanova, L., et al. (2019). Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Molecular Cancer, 18, 70. https:\/\/doi.org\/10.1186\/s12943-019-0994-2","journal-title":"Molecular Cancer"},{"key":"10248_CR107","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41420-023-01654-0","volume":"9","author":"F Cirillo","year":"2023","unstructured":"Cirillo, F., Talia, M., Santolla, M. F., et al. (2023). GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK\/c-Jun\/p53\/Noxa transduction pathway. Cell Death Discovery, 9, 353. https:\/\/doi.org\/10.1038\/s41420-023-01654-0","journal-title":"Cell Death Discovery"},{"key":"10248_CR108","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/emboj.2008.304","volume":"28","author":"DP Pandey","year":"2009","unstructured":"Pandey, D. P., Lappano, R., Albanito, L., et al. (2009). Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO Journal, 28, 523\u2013532. https:\/\/doi.org\/10.1038\/emboj.2008.304","journal-title":"EMBO Journal"},{"key":"10248_CR109","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11373-008-9264-9","volume":"15","author":"C-Y Chu","year":"2008","unstructured":"Chu, C.-Y., Chang, C.-C., Prakash, E., & Kuo, M.-L. (2008). Connective tissue growth factor (CTGF) and cancer progression. Journal of Biomedical Science, 15, 675\u2013685. https:\/\/doi.org\/10.1007\/s11373-008-9264-9","journal-title":"Journal of Biomedical Science"},{"key":"10248_CR110","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/bcr287","volume":"3","author":"RA Walker","year":"2001","unstructured":"Walker, R. A. (2001). The complexities of breast cancer desmoplasia. Breast Cancer Research, 3, 143. https:\/\/doi.org\/10.1186\/bcr287","journal-title":"Breast Cancer Research"},{"key":"10248_CR111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10911-011-9217-1","volume":"16","author":"Y Drabsch","year":"2011","unstructured":"Drabsch, Y., & ten Dijke, P. (2011). TGF-\u03b2 signaling in breast cancer cell invasion and bone metastasis. Journal of Mammary Gland Biology and Neoplasia, 16, 97\u2013108. https:\/\/doi.org\/10.1007\/s10911-011-9217-1","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"10248_CR112","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/cancers13153918","volume":"13","author":"DN Danforth","year":"2021","unstructured":"Danforth, D. N. (2021). The role of chronic inflammation in the development of breast cancer. Cancers (Basel), 13, 3918. https:\/\/doi.org\/10.3390\/cancers13153918","journal-title":"Cancers (Basel)"},{"key":"10248_CR113","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard, C., & Larriv\u00e9e, B. (2017). Tumor angiogenesis and vascular normalization: Alternative therapeutic targets. Angiogenesis, 20, 409\u2013426. https:\/\/doi.org\/10.1007\/s10456-017-9562-9","journal-title":"Angiogenesis"},{"key":"10248_CR114","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1023823803510","volume":"5","author":"DR Brigstock","year":"2002","unstructured":"Brigstock, D. R. (2002). Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis, 5, 153\u2013165. https:\/\/doi.org\/10.1023\/A:1023823803510","journal-title":"Angiogenesis"},{"key":"10248_CR115","doi-asserted-by":"publisher","first-page":"e0118957","DOI":"10.1371\/journal.pone.0118957","volume":"10","author":"MM Lacle","year":"2015","unstructured":"Lacle, M. M., van Diest, P. J., Goldschmeding, R., et al. (2015). Expression of connective tissue growth factor in male breast cancer: Clinicopathologic correlations and prognostic value. PLoS ONE, 10, e0118957. https:\/\/doi.org\/10.1371\/journal.pone.0118957","journal-title":"PLoS ONE"},{"key":"10248_CR116","doi-asserted-by":"publisher","unstructured":"Hellinger, J. W., Sch\u00f6mel, F., Buse, J. V., et al. (2020). Identification of drivers of breast cancer invasion by secretome analysis: Insight into CTGF signaling. Scientific Reports, 10,. https:\/\/doi.org\/10.1038\/s41598-020-74838-8","DOI":"10.1038\/s41598-020-74838-8"},{"key":"10248_CR117","doi-asserted-by":"publisher","unstructured":"Kim, H., Son, S., Ko, Y., et al. (2021). YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ER\u03b1. Journal of Cell Science, 134,. https:\/\/doi.org\/10.1242\/jcs.256503","DOI":"10.1242\/jcs.256503"},{"key":"10248_CR118","doi-asserted-by":"publisher","first-page":"188692","DOI":"10.1016\/j.bbcan.2022.188692","volume":"1877","author":"A Dey","year":"2022","unstructured":"Dey, A., Kundu, M., Das, S., et al. (2022). Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1877, 188692. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188692","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10248_CR119","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.tig.2015.11.003","volume":"32","author":"X Hu","year":"2016","unstructured":"Hu, X., & Zhang, Z. (2016). Understanding the genetic mechanisms of cancer drug resistance using genomic approaches. Trends in Genetics, 32, 127\u2013137. https:\/\/doi.org\/10.1016\/j.tig.2015.11.003","journal-title":"Trends in Genetics"},{"key":"10248_CR120","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","volume":"71","author":"D Lai","year":"2011","unstructured":"Lai, D., Ho, K. C., Hao, Y., & Yang, X. (2011). Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Research, 71, 2728\u20132738. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2711","journal-title":"Cancer Research"},{"key":"10248_CR121","doi-asserted-by":"publisher","first-page":"101051","DOI":"10.1016\/j.drup.2024.101051","volume":"73","author":"H Zou","year":"2024","unstructured":"Zou, H., Luo, J., Guo, Y., et al. (2024). Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer. Drug Resistance Updates, 73, 101051. https:\/\/doi.org\/10.1016\/j.drup.2024.101051","journal-title":"Drug Resistance Updates"},{"key":"10248_CR122","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12079-013-0214-6","volume":"8","author":"I Espinoza","year":"2014","unstructured":"Espinoza, I., Menendez, J. A., Kvp, C. M., & Lupu, R. (2014). CCN1 promotes vascular endothelial growth factor secretion through \u03b1 v \u03b2 3 integrin receptors in breast cancer. Journal of Cell Communication and Signaling, 8, 23\u201327. https:\/\/doi.org\/10.1007\/s12079-013-0214-6","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10248_CR123","first-page":"203","volume":"3","author":"GV Sherbet","year":"2006","unstructured":"Sherbet, G. V. (2006). Metastasis promoter S100A4 is a potential molecular therapeutic target. Cancer Genomics & Proteomics, 3, 203\u2013216.","journal-title":"Cancer Genomics & Proteomics"},{"key":"10248_CR124","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-023-05608-3","volume":"14","author":"S Son","year":"2023","unstructured":"Son, S., Kim, H., Lim, H., et al. (2023). CCN3\/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer. Cell Death & Disease, 14, 81. https:\/\/doi.org\/10.1038\/s41419-023-05608-3","journal-title":"Cell Death & Disease"},{"key":"10248_CR125","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12079-016-0345-7","volume":"10","author":"CG Kleer","year":"2016","unstructured":"Kleer, C. G. (2016). Dual roles of CCN proteins in breast cancer progression. Journal of Cell Communication and Signaling, 10, 217\u2013222. https:\/\/doi.org\/10.1007\/s12079-016-0345-7","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10248_CR126","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biocel.2010.11.013","volume":"43","author":"B Berschneider","year":"2011","unstructured":"Berschneider, B., & K\u00f6nigshoff, M. (2011). WNT1 inducible signaling pathway protein 1 (WISP1): A novel mediator linking development and disease. International Journal of Biochemistry & Cell Biology, 43, 306\u2013309. https:\/\/doi.org\/10.1016\/j.biocel.2010.11.013","journal-title":"International Journal of Biochemistry & Cell Biology"},{"key":"10248_CR127","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BJ20120311","volume":"447","author":"N Ferrand","year":"2012","unstructured":"Ferrand, N., Stragier, E., Redeuilh, G., & Sabbah, M. (2012). Glucocorticoids induce CCN5\/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells. Biochemical Journal, 447, 71\u201379. https:\/\/doi.org\/10.1042\/BJ20120311","journal-title":"Biochemical Journal"},{"key":"10248_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12079-011-0148-9","volume":"6","author":"W Huang","year":"2012","unstructured":"Huang, W., Pal, A., & Kleer, C. G. (2012). On how CCN6 suppresses breast cancer growth and invasion. Journal of Cell Communication and Signaling, 6, 5\u201310. https:\/\/doi.org\/10.1007\/s12079-011-0148-9","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10248_CR129","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nrd3599","volume":"10","author":"JJ Il","year":"2011","unstructured":"Il, J. J., & Lau, L. F. (2011). Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nature Reviews Drug Discovery, 10, 945\u2013963.","journal-title":"Nature Reviews Drug Discovery"},{"key":"10248_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.01-0332fje","volume":"16","author":"I Inoki","year":"2002","unstructured":"Inoki, I., Shiomi, T., Hashimoto, G., et al. (2002). Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. The FASEB Journal, 16, 1\u201327. https:\/\/doi.org\/10.1096\/fj.01-0332fje","journal-title":"The FASEB Journal"},{"key":"10248_CR131","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jnci\/djj242","volume":"98","author":"C-C Chang","year":"2006","unstructured":"Chang, C.-C., Lin, M.-T., Lin, B.-R., et al. (2006). Effect of connective tissue growth factor on hypoxia-inducible factor 1\u03b1 degradation and tumor angiogenesis. JNCI: Journal of the National Cancer Institute, 98, 984\u2013995. https:\/\/doi.org\/10.1093\/jnci\/djj242","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10248_CR132","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000055339","volume":"61","author":"T Shimo","year":"2001","unstructured":"Shimo, T., Nakanishi, T., Nishida, T., et al. (2001). Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology, 61, 315\u2013322. https:\/\/doi.org\/10.1159\/000055339","journal-title":"Oncology"},{"key":"10248_CR133","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2017.01.013","volume":"391","author":"L-H Wang","year":"2017","unstructured":"Wang, L.-H., Tsai, H.-C., Cheng, Y.-C., et al. (2017). CTGF promotes osteosarcoma angiogenesis by regulating miR-543\/angiopoietin 2 signaling. Cancer Letters, 391, 28\u201337. https:\/\/doi.org\/10.1016\/j.canlet.2017.01.013","journal-title":"Cancer Letters"},{"key":"10248_CR134","first-page":"8917","volume":"61","author":"D Xie","year":"2001","unstructured":"Xie, D., Nakachi, K., Wang, H., et al. (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Research, 61, 8917\u20138923.","journal-title":"Cancer Research"},{"key":"10248_CR135","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4161\/mabs.2.2.11304","volume":"2","author":"R Mamluk","year":"2010","unstructured":"Mamluk, R., Carvajal, I. M., Morse, B. A., et al. (2010). Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2. MAbs, 2, 199\u2013208. https:\/\/doi.org\/10.4161\/mabs.2.2.11304","journal-title":"MAbs"},{"key":"10248_CR136","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1359\/jbmr.060416","volume":"21","author":"T Shimo","year":"2006","unstructured":"Shimo, T., Kubota, S., Yoshioka, N., et al. (2006). Pathogenic role of connective tissue growth factor (CTGF\/CCN2) in osteolytic metastasis of breast cancer. Journal of Bone and Mineral Research, 21, 1045\u20131059. https:\/\/doi.org\/10.1359\/jbmr.060416","journal-title":"Journal of Bone and Mineral Research"},{"key":"10248_CR137","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-4-4","volume":"4","author":"Q Wang","year":"2011","unstructured":"Wang, Q., Usinger, W., Nichols, B., et al. (2011). Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease. Fibrogenesis Tissue Repair, 4, 4. https:\/\/doi.org\/10.1186\/1755-1536-4-4","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10248_CR138","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1183\/13993003.01030-2015","volume":"47","author":"G Raghu","year":"2016","unstructured":"Raghu, G., Scholand, M. B., de Andrade, J., et al. (2016). FG-3019 anti-connective tissue growth factor monoclonal antibody: Results of an open-label clinical trial in idiopathic pulmonary fibrosis. European Respiratory Journal, 47, 1481\u20131491. https:\/\/doi.org\/10.1183\/13993003.01030-2015","journal-title":"European Respiratory Journal"},{"key":"10248_CR139","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1093\/hmg\/ddy204","volume":"27","author":"D Gonzalez","year":"2018","unstructured":"Gonzalez, D., Rebolledo, D. L., Correa, L. M., et al. (2018). The inhibition of CTGF\/CCN2 activity improves muscle and locomotor function in a murine ALS model. Human Molecular Genetics, 27, 2913\u20132926. https:\/\/doi.org\/10.1093\/hmg\/ddy204","journal-title":"Human Molecular Genetics"},{"key":"10248_CR140","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/13543784.2020.1773790","volume":"29","author":"G Sgalla","year":"2020","unstructured":"Sgalla, G., Franciosa, C., Simonetti, J., & Richeldi, L. (2020). Pamrevlumab for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs, 29, 771\u2013777. https:\/\/doi.org\/10.1080\/13543784.2020.1773790","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10248_CR141","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","volume":"68\u201369","author":"Y Ramazani","year":"2018","unstructured":"Ramazani, Y., Knops, N., Elmonem, M. A., et al. (2018). Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biology, 68\u201369, 44\u201366. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.007","journal-title":"Matrix Biology"},{"key":"10248_CR142","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/acs.molpharmaceut.3c01161","volume":"21","author":"S Nandi","year":"2024","unstructured":"Nandi, S., Bhaduri, S., Das, D., et al. (2024). Deciphering the lexicon of protein targets: A review on multifaceted drug discovery in the era of artificial intelligence. Molecular Pharmaceutics, 21, 1563\u20131590. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c01161","journal-title":"Molecular Pharmaceutics"},{"key":"10248_CR143","doi-asserted-by":"publisher","first-page":"16307","DOI":"10.3390\/ijms242216307","volume":"24","author":"JH Lee","year":"2023","unstructured":"Lee, J. H., Kim, J., Kim, H. S., & Kang, Y. J. (2023). Unraveling connective tissue growth factor as a therapeutic target and assessing kahweol as a potential drug candidate in triple-negative breast cancer treatment. International Journal of Molecular Sciences, 24, 16307. https:\/\/doi.org\/10.3390\/ijms242216307","journal-title":"International Journal of Molecular Sciences"},{"key":"10248_CR144","doi-asserted-by":"publisher","unstructured":"Wang, M., Li, X. Z., Zhang, M. X., et al. (2021). Atractylenolide-I sensitizes triple-negative breast cancer cells to paclitaxel by blocking CTGF expression and fibroblast activation. Frontiers in Oncology, 11,. https:\/\/doi.org\/10.3389\/fonc.2021.738534","DOI":"10.3389\/fonc.2021.738534"},{"key":"10248_CR145","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jep.2016.05.012","volume":"188","author":"CH Chang","year":"2016","unstructured":"Chang, C. H., Ou, T. T., Yang, M. Y., et al. (2016). Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K\/AKT\/ERK signaling. Journal of Ethnopharmacology, 188, 111\u2013122. https:\/\/doi.org\/10.1016\/j.jep.2016.05.012","journal-title":"Journal of Ethnopharmacology"},{"key":"10248_CR146","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.19540\/j.cnki.cjcmm.20230510.706","volume":"48","author":"H-L Ou","year":"2023","unstructured":"Ou, H.-L., Wu, H., Ren, Y.-L., et al. (2023). Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP. Zhongguo Zhong Yao Za Zhi, 48, 4483\u20134492. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20230510.706","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10248_CR147","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/gt.2008.25","volume":"15","author":"W-F Cheng","year":"2008","unstructured":"Cheng, W.-F., Chang, M.-C., Sun, W.-Z., et al. (2008). Connective tissue growth factor linked to the E7 tumor antigen generates potent antitumor immune responses mediated by an antiapoptotic mechanism. Gene Therapy, 15, 1007\u20131016. https:\/\/doi.org\/10.1038\/gt.2008.25","journal-title":"Gene Therapy"},{"key":"10248_CR148","doi-asserted-by":"publisher","first-page":"10933","DOI":"10.1038\/s41598-022-15118-5","volume":"12","author":"T Nakayama","year":"2022","unstructured":"Nakayama, T., Azegami, T., Hayashi, K., et al. (2022). Vaccination against connective tissue growth factor attenuates the development of renal fibrosis. Science and Reports, 12, 10933. https:\/\/doi.org\/10.1038\/s41598-022-15118-5","journal-title":"Science and Reports"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10248-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T03:02:41Z","timestamp":1743303761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10248-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10248"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10248-4","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"12 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Resources"}}],"article-number":"32"}}